HPB Session 1

Moderator(s)

• 

  Alexandra Gangi, MD

  Assistant Professor Director, Gastrointestinal Tumor Program
  Cedars Sinai Medical Center
  Los Angeles, California, United States
• 

  Sepideh Gholami, MD

  Hepato-Pancreato-Biliary Surgeon
  University of California Davis Health
  Sacramento, California, United States

Oral Abstract Presenter(s)

• 

  John Creasy, MD

  Fellow, Surgical Oncology
  Duke University Medical Center
• 

  Tracey Pu, BS

  Fourth Year Medical Student
  Wake Forest School of Medicine, North Carolina, United States
• 

  Erin Strong, MD, MBA

  Resident
  Medical College of Wisconsin
  Milwaukee, Wisconsin, United States
• 

  G. Paul Wright, MD

  Assistant Professor of Surgery
  Spectrum Health/Michigan State University
  Grand Rapids, Michigan, United States

Presentations:

• 7:30 AM – 7:45 AM

  A Phase II Trial of Hepatic Artery Infusional Floxuridine With Systemic Chemotherapy in the Treatment of Pancreatic Cancer Liver Metastases
  G. Paul Wright, MD – Spectrum Health/Michigan State University
• 7:45 AM – 8:00 AM

  Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent HAI and Systemic Chemotherapy for Colorectal Liver Metastases
  John M. Creasy, MD – Duke University Medical Center
• 8:00 AM – 8:15 AM

  Role of Intraoperative Margin Treatment for Resection of Colorectal Liver Metastases
  Tracey Pu, BS – Wake Forest School of Medicine
• 8:15 AM – 8:30 AM

  Safety and Efficacy of Peptide Receptor Radionucleotide Therapy (PRRT) in Metastatic Neuroendocrine Tumors: A US Single-Institution Experience Post-FDA Approval
  Erin A. Strong, MD, MBA – Medical College of Wisconsin
• 8:30 AM – 9:30 AM

  Metastatic Neuroendocrine Tumor Confined to the Liver
  Sepideh Gholami, MD – University of California Davis Health; Alexandra Gangi, MD – Cedars Sinai Medical Center